Circadin®, a novel prolonged release formulation, is able to mimic the internal melatonin secretion profile by releasing melatonin gradually over 8-10 hours from the time it’s is being swallowed.
In well controlled clinical trials in thousands of insomnia patients, Circadin® has been proven to help patients to fall asleep easily and have a good night sleep, allowing them to wake-up feeling refreshed and ready for the next day.
Circadin® is the first sleep agent to demonstrate improvements in next day functioning and Quality of Life and is the only licensed medication containing melatonin.
Because of its proven efficacy and long term safety Circadin® is the only sleep drug approved for treatment for up to 13 weeks, without being restricted to several days as other insomnia drugs.
Want to hear more about Circadin®? click here!
